Abstract
BackgroundIn clinical trials of systemic sclerosis (SSc), there is an unmet need for better inclusion criteria to enrich for patients with progressive skin fibrosis [1,2]. Recent trials on skin fibrosis...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
